U.S. Metals and Mining Stock News

If you have been wondering whether Citizens Financial Group is still a bargain after its latest run up, you are not alone. This article is going to unpack exactly what you might be paying for at today’s price. The stock has climbed 5.0% over the last week, 11.7% over the past month, and is now up 34.1% year to date, building on a 31.3% 1 year gain and more than doubling investors’ money over 5 years with a 104.4% total return. Recent moves have been driven by a mix of improving sentiment...

ExlService Holdings (EXLS) has quietly slipped this year, with the stock down around 12% over the past year even as revenue and net income each grew roughly 11% annually, creating an interesting disconnect. See our latest analysis for ExlService Holdings. Despite this weak patch, the mood around ExlService has steadied a bit. A 1 month share price return of 2.88 percent has lifted the stock to about 40.77 dollars, while its 5 year total shareholder return of 140.08 percent shows long term...

Thermo Fisher Scientific (TMO) has been back in the spotlight after a wave of upbeat coverage from major banks, tying its stock story to improving life sciences demand and fresh bioprocessing expansion across Asia. See our latest analysis for Thermo Fisher Scientific. Those Asia bioprocessing moves and the new cardiac risk test partnership have arrived just as sentiment is turning, with Thermo Fisher’s share price up 16.8 percent over 90 days and its 1 year total shareholder return at 7.8...

Biohaven Ltd. recently presented clinical safety and efficacy data from its novel Trop2-directed antibody-drug conjugate BHV-1510, in combination with Regeneron’s anti-PD-1 cemiplimab, at the 2025 ESMO Immuno-Oncology Congress in London, showing meaningful response rates and manageable safety across several tumor types. The data, including strong objective response rates in non-small cell lung, endometrial, urothelial and triple negative breast cancers, underscores Biohaven’s growing...

PepsiCo (PEP) just laid out a sweeping turnaround plan with activist investor Elliott that combines price cuts, a leaner US product lineup, and aggressive cost savings, and JPMorgan has already responded by turning more optimistic on the stock. See our latest analysis for PepsiCo. The flurry of activism news, refreshed guidance for 2025 and 2026, and even splashy marketing moves like the Mercedes F1 partnership help explain why PepsiCo’s recent 30 day share price return of 4.96% contrasts...

In late November and early December 2025, Rockwell Automation announced cloud-native upgrades to its Manufacturing Execution System portfolio and deepened its Saudi presence via a collaboration with alfanar, including a new automation panel manufacturing zone in Riyadh serving critical infrastructure projects like the Saudi Water Authority. These moves highlight Rockwell Automation’s push to embed its technology at the core of digitally enabled industrial operations, linking software,...

Lockheed Martin (LMT) has been quietly grinding higher, with the stock up about 4% over the past week and 2% over the past month, even as year to date returns remain slightly negative. See our latest analysis for Lockheed Martin. At around $467.94 per share, Lockheed Martin is edging higher again, with recent share price gains hinting that sentiment may be turning after a weaker year to date, even though the five year total shareholder return still looks solid. If this renewed interest in...

GE HealthCare Technologies (GEHC) has quietly pushed higher recently, with the stock up about 15% over the past month and roughly 8% in the past 3 months, outpacing many healthcare peers. See our latest analysis for GE HealthCare Technologies. Zooming out, the stock’s roughly 15% 1 month share price return and 7.8% year to date share price return, alongside a modest 1 year total shareholder return of just over 2%, point to momentum that has picked up recently rather than been sustained all...

Wondering if Medical Properties Trust at around $5.50 is a bargain or a value trap? You are not alone. This stock has become a lightning rod for income investors trying to separate recovery potential from real risk. After a brutal multi year slide, the shares are still down 39.6% over 3 years and 61.6% over 5 years, but they have bounced 37.1% year to date and 43.6% over the last year, including an 11.1% gain in the past month despite a minor 2.0% pullback this week. That rebound has played...

D.R. Horton (DHI) shares inched higher in the latest session, extending a mixed stretch where gains this month contrast with weaker performance over the past 3 months and prompting a closer look at what the market is pricing in. See our latest analysis for D.R. Horton. With the share price now around $155, D.R. Horton’s 1 month share price return of 7.4 percent and modest 1 year total shareholder return of 2.2 percent suggest momentum is rebuilding after a choppy few months. If this move has...

In recent months, Sociedad Química y Minera de Chile placed UF10 million in series S bonds for general corporate purposes and debt refinancing, while also reporting record third-quarter sales amid recovering demand and pricing. At the same time, the company outlined a US$2.70 billion investment plan through 2027 to expand lithium carbonate capacity and deepen its partnership with state miner Codelco in the Atacama salt flat, underscoring an intensified focus on long-term lithium...

If you are wondering whether Heidrick & Struggles International is still a smart buy after such a strong run, you are not alone. This is exactly what we are going to unpack here. The stock has climbed 33.9% year to date and is up 30.4% over the last year, while longer term holders have seen gains of 108.8% over 3 years and 122.8% over 5 years, all from a recent close of $59.01. Those gains have come as investors have warmed to the company’s positioning in higher value advisory and leadership...

Trane Technologies (TT) has been treading water lately, with the stock roughly flat over the past year after a strong multi year run, even as revenue and net income continue to grow steadily. See our latest analysis for Trane Technologies. At around a 7 percent year to date share price return and a powerful five year total shareholder return of just over 200 percent, Trane’s recent consolidation near 399.14 looks more like a pause after a long rally than a trend break. Investors are...

Assessing AbbVie after a strong run AbbVie (ABBV) has quietly delivered solid gains this year, and with the stock recently closing around 225 dollars, investors are asking whether the current momentum still lines up with fundamentals. See our latest analysis for AbbVie. The 1 year total shareholder return of 33.65 percent, alongside a year to date share price return of 25.49 percent with the stock now at 225.18 dollars, suggests momentum is still building rather than fading. If AbbVie’s run...

On 9 December 2025, Rocket Companies presented at the Goldman Sachs 2025 U.S. Financial Services Conference, updating investors on how its acquisitions and technology platform are reshaping its nationwide mortgage and real estate services. Management highlighted that early Redfin integration is already driving more Redfin buyers to choose Rocket mortgages and supporting very strong growth in home equity lending, underscoring the company’s push to deepen customer engagement across its...

If you are wondering whether Walmart is still good value after its huge run, or if you have already missed the boat, this breakdown will help you see what the market might be getting right or wrong about the stock. Walmart has climbed 25.8% year to date and 21.5% over the last year, with a strong 9.4% move in the past month even after a small 1.4% dip over the last week. This signals that sentiment has turned decisively more optimistic. Recent headlines have focused on Walmart doubling down...

BofA Securities just cooled on PROCEPT BioRobotics (PRCT), downgrading the stock to neutral after flagging slower utilization of its aquablation systems and softer system sales as hospital capital budgets tighten. See our latest analysis for PROCEPT BioRobotics. Investors have already been wrestling with this shift in sentiment, with a 1 month share price return of 13.94 percent offering only a brief rebound against a year to date share price loss of 57.06 percent and a 1 year total...

The latest Federal Reserve rate cut lit a fire under Abercrombie & Fitch (ANF), with shares jumping as investors leaned into interest rate sensitive retail names and revisited the company’s improving sales and technology-driven execution. See our latest analysis for Abercrombie & Fitch. That surge comes on top of a powerful 1 month share price return of roughly 49 percent, yet the stock is still down sharply year to date even after record sales, tech upgrades like the Nedap iD Cloud rollout,...

On 2 December 2025, First Interstate BancSystem, Inc. was added to the S&P 1000 index, joining a broader cohort of small- and mid-cap U.S. companies. This index inclusion could broaden the bank’s investor base as index-tracking funds and benchmark-aware investors reassess its role in diversified portfolios. We’ll now explore how First Interstate’s addition to the S&P 1000 could influence its investment narrative, particularly around capital flexibility. The latest GPUs need a type of rare...

In recent days, VinFast Auto has signed agreements with five Indonesian companies, including Goodyear Indonesia, Dunlop, Denso Sales Indonesia, CARfix, and Scuto Paint, to build out a comprehensive aftermarket and after-sales ecosystem for its electric vehicles in the country. Together with its push into full-scale EV production and new plants across Southeast Asia and India, these partnerships highlight VinFast’s attempt to pair regional manufacturing expansion with local service depth,...

Booz Allen Hamilton’s inclusion in the S&P MidCap 400 index, announced as part of a recent S&P indices rebalancing, has prompted large index-tracking funds to adjust portfolios to reflect the company’s new status. This index entry highlights how benchmark membership can influence trading activity and investor attention without any immediate change in Booz Allen’s underlying operations or contracts. We’ll now explore how Booz Allen’s S&P MidCap 400 inclusion may influence its investment...

Wondering if EQT is still a smart buy after its big run over the last few years, or if most of the easy money has already been made? This breakdown is designed to help you decide. The stock is down 6.4% over the last week and 2.9% over the last month, but it is still up 20.9% year to date and 27.1% over the past year, building on a 347.8% gain over 5 years. Recent moves in EQT have been shaped by shifting natural gas price expectations and ongoing policy debates around U.S. energy...

Eclipse Energy recently announced that Weatherford International will partner with it and invest capital to deploy microbe technology that converts residual oil in abandoned wells into low-carbon hydrogen, with joint projects slated to begin in January 2026. This partnership signals Weatherford’s push to repurpose legacy oilfield infrastructure for cleaner energy applications, aligning its service portfolio with the emerging hydrogen economy. We’ll now examine how Weatherford’s move into...

Chime Financial (CHYM) has quietly beaten the broader fintech space over the past month, with the stock up roughly 25% even as its year to date return remains down almost 29%. See our latest analysis for Chime Financial. The recent 30 day share price return of 24.65 percent, including a 9.10 percent jump in the last session to 26.50 dollars, suggests momentum is rebuilding even though the year to date share price return remains firmly negative. If Chime’s rebound has you rethinking the...